Radiology Department, The 980 Hospital of PLA Logistic Force, Shijiazhuang 050082, Hebei, China.
Tumor and Vascular Surgery Department, Anping People's Hospital, Hengshui 053600, Hebei, China.
J Healthc Eng. 2022 Jan 25;2022:1424021. doi: 10.1155/2022/1424021. eCollection 2022.
Prostatic hyperplasia can cause dysuria, such as frequent urination, urgency of urination, increased nocturia, poor urination, and other symptoms, which seriously affect the quality of life of old men. We aim to compare and analyze the safety and clinical effect of embolization of the target blood vessels of ruptured prostatic hyperplasia with gelatin sponge particles and embosphere microspheres. . The transcatheter MRI was performed in 422 patients. Among them, 198 patients were treated with gelfoam particles and 224 patients were treated with embosphere microspheres. The clinical effect and adverse reactions were observed and analyzed by biochemical and imaging examination. Four hundred and twenty two cases were hemostasis. In the gelatin sponge group, 34 patients had recurrent bleeding 24-36 hours after embolization, 122 patients had different degrees of elevation of prostatic hyperplasia transaminase (31 cases increased to more than 1000 U/L), 198 patients had different degrees of elevation of bilirubin; in the microsphere group, there was no significant difference in prostatic hyperplasia function indexes between the two groups. . Compared with the gelfoam embolic agent, the embosphere embolic microsphere has a good efficacy and safety in the treatment of prostatic hyperplasia rupture and hemorrhage, with a light adverse reaction, a low probability of recanalization, and little damage to the postoperative prostatic hyperplasia function, which is conducive to the benign recovery of perioperative patients and is worthy of clinical application.
前列腺增生可引起排尿困难,如尿频、尿急、夜尿增多、排尿不畅等症状,严重影响老年男性的生活质量。我们旨在比较和分析破裂性前列腺增生靶血管栓塞术用明胶海绵颗粒和 EmboSphere 微球的安全性和临床效果。对 422 例患者进行了经导管 MRI 检查。其中 198 例患者接受明胶海绵颗粒治疗,224 例患者接受 EmboSphere 微球治疗。通过生化和影像学检查观察和分析临床效果和不良反应。422 例患者均止血成功。在明胶海绵组,栓塞后 24-36 小时 34 例患者出现再次出血,122 例患者前列腺增生转氨酶(31 例升高至 1000 U/L 以上)不同程度升高,198 例患者胆红素不同程度升高;微球组两组前列腺增生功能指标差异无统计学意义。与明胶海绵栓塞剂相比,EmboSphere 栓塞微球在治疗前列腺增生破裂出血方面具有良好的疗效和安全性,不良反应较轻,再通概率低,对术后前列腺增生功能损伤小,有利于围手术期患者的良性恢复,值得临床应用。